Role of PKG-L-type calcium channels in the antinociceptive effect of intrathecal sildenafil

Journal of Veterinary Science

Volumn 11, Issue 1, 2010, Pages 103-106

  Kim, Woong Mo ^a   Yoon, Myung Ha ^a,b   Cui, Jin Hua ^b  

^a Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Formalin test; L type calcium channel; PKG; Sildenafil; Spinal cord

Indexed keywords

RATTUS;

4 (2 BENZYLBENZOYL) 2,5 DIMETHYL 1H PYRROLE 3 CARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL L TYPE; CALCIUM CHANNEL STIMULATING AGENT; CARBAZOLE DERIVATIVE; CYCLIC GMP DEPENDENT PROTEIN KINASE; KT 5823; PIPERAZINE DERIVATIVE; PROTEIN KINASE INHIBITOR; PURINE DERIVATIVE; PYRROLE DERIVATIVE; SILDENAFIL; SULFONE;

ANIMAL; ARTICLE; DOSE RESPONSE; DRUG ANTAGONISM; MALE; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CALCIUM CHANNEL AGONISTS; CALCIUM CHANNELS, L-TYPE; CARBAZOLES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; PAIN; PAIN MEASUREMENT; PIPERAZINES; PROTEIN KINASE INHIBITORS; PURINES; PYRROLES; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 77952725115     PISSN: 1229845X     EISSN: None     Source Type: Journal    
DOI: 10.4142/jvs.2010.11.2.103     Document Type: Article

References (22)

1. Araiza-Saldaña CI, Reyes-García G, Bermúdez-Ocaña DY, Pérez-Severiano F, Granados-Soto V. Effect of diabetes on the mechanisms of intrathecal antinociception of sildenafil in rats. Eur J Pharmacol 2005, 527, 60-70.
2. Beavo JA. Cyclic nucleotide phosphodiesterases: functional implications of multiple isoforms. Physiol Rev 1995, 75, 725-748.
3. Beavo JA, Reifsnyder DH. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 1990, 11, 150-155.
4. Boolell M, Gepi-Attee S, Gingell JC, Allen MJ. Sildenafil, a novel effective oral therapy for male erectile dysfunction. Br J Urol 1996, 78, 257-261.
5. Bowersox SS, Gadbois T, Singh T, Pettus M, Wang YX, Luther RR. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain. J Pharmacol Exp Ther 1996, 279, 1243-1249.
6. Coderre TJ, Melzack R. The role of NMDA receptoroperated calcium channels in persistent nociception after formalin-induced tissue injury. J Neurosci 1992, 12, 3671-3675.
7. de Vente J, Markerink-van Ittersum M, Vles JS. The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord. J Chem Neuroanat 2006, 31, 275-303.
8. Fukuizumi T, Ohkubo T, Kitamura K. Spinally delivered N-, P/Q-and L-type Ca2+-channel blockers potentiate morphine analgesia in mice. Life Sci 2003, 73, 2873-2881.
9. Galeotti N, Bartolini A, Ghelardini C. Role of intracellular calcium in acute thermal pain perception. Neuropharmacology 2004, 47, 935-944.
10. Gibson A. Phosphodiesterase 5 inhibitors and nitrergic transmission-from zaprinast to sildenafil. Eur J Pharmacol 2001, 411, 1-10.
11. Hara K, Saito Y, Kirihara Y, Sakura S, Kosaka Y. Antinociceptive effects of intrathecal L-type calcium channel blockers on visceral and somatic stimuli in the rat. Anesth Analg 1998, 87, 382-387.
12. Miller RJ. Multiple calcium channels and neuronal function. Science 1987, 235, 46-52.
13. Mixcoatl-Zecuatl T, Aguirre-Bañuelos P, Granados-Soto V. Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur J Pharmacol 2000, 400, 81-87.
14. Pyne NJ, Arshavsky V, Lochhead A. cGMP signal termination. Biochem Soc Trans 1996, 24, 1019-1022.
15. Salom JB, Castelló-Ruiz M, Burguete MC, Guzmán C, Jover-Mengual T, Torregrosa G, Jover R, Lizasoain I, Alborch E. Role of K+ and Ca2+ fluxes in the cerebroarterial vasoactive effects of sildenafil. Eur J Pharmacol 2008, 581, 138-147.
16. Sousa AM, Prado WA. The dual effect of a nitric oxide donor in nociception. Brain Res 2001, 897, 9-19.
17. Ückert S, Hedlund P, Andersson KE, Truss MC, Jonas U, Stief CG. Update on phosphodiesterase (PDE) isoenzymes as pharmacologic targets in urology: present and future. Eur Urol 2006, 50, 1194-1207.
18. Wang X, Robinson PJ. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J Neurochem 1997, 68, 443-456.
19. Westenbroek RE, Hoskins L, Catterall WA. Localization of Ca2+ channel subtypes on rat spinal motor neurons, interneurons, and nerve terminals. J Neurosci 1998, 18, 6319-6330.
20. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17, 1031-1036.
21. Yoon MH, Kim WM, Lee HG, Kim YO, Huang LJ, An TH. Roles of opioid receptor subtypes on the antinociceptive effect of intrathecal sildenafil in the formalin test of rats. Neurosci Lett 2008, 441, 125-128.
22. Yoshimura N, Seki S, de Groat WC. Nitric oxide modulates Ca2+ channels in dorsal root ganglion neurons innervating rat urinary bladder. J Neurophysiol 2001, 86, 304-311